Rhinovirus in the pathogenesis and clinical course of asthma

Chest

Volumn 148, Issue 6, 2015, Pages 1508-1516

  Jamieson, Kyla C ^a   Warner, Stephanie M ^a   Leigh, Richard ^a   Proud, David ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INTERFERON; MATRIX PROTEIN;

AIRWAY REMODELING; ARTICLE; ASTHMA; CLINICAL PRACTICE; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EPITHELIUM; GENETIC SUSCEPTIBILITY; HOST RESISTANCE; HUMAN; HUMAN RHINOVIRUS; INFECTION SENSITIVITY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHINOVIRUS INFECTION; VIRUS PATHOGENESIS; DISEASE COURSE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; PICORNAVIRUS INFECTION; RHINOVIRUS; RISK FACTOR; VIROLOGY;

AIRWAY REMODELING; ASTHMA; DISEASE PROGRESSION; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; RISK FACTORS;

EID: 84949034260     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-1335     Document Type: Article

References (59)

1. Palmenberg AC, Rathe JA, Liggett SB. Analysis of the complete genome sequences of human rhinovirus. J Allergy Clin Immunol. 2010;125(6):1190-1199.
2. Gern JE. How rhinovirus infections cause exacerbations of asthma. Clin Exp Allergy. 2015;45(1):32-42.
3. Bochkov YA, Watters K, Ashraf S, et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci USA. 2015;112(17):5485-5490.
4. Bizzintino J, Lee W-M, Laing IA, et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J. 2011;37(5):1037-1042.
5. Lee W-M, Lemanske RF Jr, Evans MD, et al. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med. 2012;186(9):886-891.
6. McCulloch DJ, Sears MH, Jacob JT, et al. Severity of rhinovirus infection in hospitalized adults is unrelated to genotype. Am J Clin Pathol. 2014;142(2):165-172.
7. Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis. 2000;181(6):1875-1884.
8. Mosser AG, Vrtis R, Burchell L, et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med. 2005;171(6):645-651.
9. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178(7):667-672.
10. Feldman AS, He Y, Moore ML, Hershenson MB, Hartert TV. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modif able risk factors to prevent childhood asthma. Am J Respir Crit Care Med. 2015;191(1): 34-44.
11. Heymann PW, Carper HT, Murphy DD, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004;114(2): 239-247.
12. Jartti T, Lehtinen P, Vuorinen T, et al. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis. 2004; 10 (6): 1095-1101.
13. Bønnelykke K, Vissing NH, Sevelsted A, Johnston SL, Bisgaard H. Association between respiratory infections in early life and later asthma is independent of virus type. J Allergy Clin Immunol. 2015;136(1):81-86.
14. Jartti T, Lee W-M, Pappas T, Evans M, Lemanske RF Jr, Gern JE. Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J. 2008;32(2):314-320.
15. Ober C, Yao T-C. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev. 2011;242(1):10-30.
16. Mofatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 2007;448(7152):470-473.
17. Çaliskan M, Bochkov YA, Kreiner-Møller E, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med. 2013;368(15):1398-1407.
18. Bønnelykke K, Sleiman P, Nielsen K, et al. A genome-wide association study identif es CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet. 2014;46(1): 51-55.
19. Bai J, Smock SL, Jackson GRJ Jr, et al. Phenotypic responses of differentiated asthmatic human airway epithelial cultures to rhino-virus. PLoS One. 2015;10(2):e0118286.
20. Jackson DJ, Evans MD, Gangnon RE, et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med. 2012;185(3):281-285.
21. Jefery PK. Remodeling and inf ammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1(3):176-183.
22. Loxham M, Davies DE, Blume C. Epithelial function and dysfunction in asthma. Clin Exp Allergy. 2014;44(11):1299-1313.
23. James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J. 2007;30(1):134-155.
24. Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inf ammation in preschool wheezers. Am J Respir Crit Care Med. 2007;176(9):858-864.
25. O'Reilly R, Ullmann N, Irving S, et al. Increased airway smooth muscle in preschool wheezers who have asthma at school age. J Allergy Clin Immunol. 2013;131(4):1024-1032.
26. Saglani S, Malmström K, Pelkonen AS, et al. Airway remodeling and inf ammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med. 2005;171(7):722-727.
27. Zhu L, Lee PK, Lee W-M, Zhao Y, Yu D, Chen Y. Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. Am J Respir Cell Mol Biol. 2009;40(5):610-619.
28. Hewson CA, Haas JJ, Bartlett NW, et al. Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-k B and EGFR pathways. Eur Respir J. 2010;36(6):1425-1435.
29. Sajjan U, Wang Q, Zhao Y, Gruenert DC, Hershenson MB. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med. 2008;178(12):1271-1281.
30. Xiao C, Puddicombe SM, Field S, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011; 128 (3): 549-556.
31. Jakiela B, Gielicz A, Plutecka H, et al. T 2-type cytokine-induced mucus metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection. Am J Respir Cell Mol Biol. 2014;51(2):229-241.
32. Leigh R, Oyelusi W, Wiehler S, et al. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol. 2008; 121(5):1238-1245.e4.
33. Kuo C, Lim S, King NJC, et al. Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo. Respirology. 2011;16(2):367-377.
34. Tacon CE, Wiehler S, Holden NS, Newton R, Proud D, Leigh R. Human rhinovirus infection up-regulates MMP-9 production in airway epithelial cells via NF-kB. Am J Respir Cell Mol Biol. 2010;43(2):201-209.
35. Kuo C, Lim S, King NJC, et al. Rhinovirus infection induces extracellular matrix protein deposition in asthmatic and nonasthmatic airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2011;300(6):L951-L957.
36. Khetsuriani N, Kazerouni NN, Erdman DD, et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol. 2007;119(2):314-321.
37. Kistler A, Avila PC, Rouskin S, et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis. 2007;196(6):817-825.
38. DeMore JP, Weisshaar EH, Vrtis RF, et al. Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J Allergy Clin Immunol. 2009;124(2): 245-252.
39. Iikura M, Hojo M, Koketsu R, et al. The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice. PLoS One. 2015;10(4):e0123584.
40. Proud D, Leigh R. Epithelial cells and airway diseases. Immunol Rev. 2011;242(1):186-204.
41. Proud D, Turner RB, Winther B, et al. Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am J Respir Crit Care Med. 2008;178(9):962-968.
42. Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med. 2000;162(6): 2226-2231.
43. Spurrell JCL, Wiehler S, Zaheer RS, Sanders SP, Proud D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol. 2005;289(1):L85-L95.
44. Wark PAB, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a def cient innate immune response to infection with rhinovirus. J Exp Med. 2005;201(6):937-947.
45. Contoli M, Message SD, Laza-Stanca V, et al. Role of def cient type III interferon-l production in asthma exacerbations. Nat Med. 2006;12(9):1023-1026.
46. Lopez-Souza N, Favoreto S, Wong H, et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol. 2009;123(6):1384-1390.
47. Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 2010;3(1):69-80.
48. Kennedy JL, Shaker M, McMeen V, et al. Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Am J Respir Crit Care Med. 2014; 189 (5): 532-539.
49. Schneider D, Ganesan S, Comstock AT, et al. Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 182(3):332-340.
50. Proud D, Hudy MH, Wiehler S, et al. Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genes. PLoS One. 2012;7(7):e40762.
51. Bochkov YA, Busse WW, Brockman-Schneider RA, et al. Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses. Respir Res. 2013; 14: 98.
52. Schmid S, Mordstein M, Kochs G, García-Sastre A, Tenoever BR. Transcription factor redundancy ensures induction of the antiviral state. J Biol Chem. 2010;285(53):42013-42022.
53. Rowe BH, Edmonds ML, Spooner CH, Diner B, Camargo CA Jr. Corticosteroid therapy for acute asthma. Respir Med. 2004;98(4): 275-284.
54. Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364(11):1005-1015.
55. Ortega HG, Liu MC, Pavord ID, et al; MENSA Investigators. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371(13):1198-1207.
56. Glanville N, Johnston SL. Challenges in developing a cross-serotype rhinovirus vaccine. Curr Opin Virol. 2015;11:83-88.
57. Leigh R, Proud D. Virus-induced modulation of lower airway diseases: pathogenesis and pharmacologic approaches to treatment. Pharmacol Ther. 2015;148:185-198.
58. Djukanovic R, Harrison T, Johnston SL, et al; INTERCIA Study Group. The effect of inhaled IFN-b on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med. 2014;190(2):145-154.
59. Proud D. Nitric oxide and the common cold. Curr Opin Allergy Clin Immunol. 2005;5(1):37-42.